key: cord-0268898-7s7qxzqh
authors: Zandhuis, Nordin D.; Nicolet, Benoit P.; Wolkers, Monika C.
title: Mapping RNA-binding proteins in human B cells and T cells upon differentiation
date: 2021-06-10
journal: bioRxiv
DOI: 10.1101/2021.06.10.447413
sha: c706c17305d9bbac58ede54e92e6ebb44376c35e
doc_id: 268898
cord_uid: 7s7qxzqh

B cells and T cells are key players in the defence against infections and malignancies. To exert their function, B cells and T cells differentiate into effector and memory cells. Tight regulation of these differentiation processes is key to prevent their malfunction, which can result in life-threatening disease. Lymphocyte differentiation relies on the appropriate timing and dosage of regulatory molecules, and post-transcriptional gene regulation (PTR) is a key player herein. PTR includes the regulation through RNA-binding proteins (RBPs), which control the fate of RNA and its translation into proteins. To date, a comprehensive RBP expression map throughout lymphocyte differentiation is lacking. Using transcriptome and proteome analyses, we here provide an RBP expression map for human B cells and T cells. We observed that even though the overall RBP expression is conserved, the relative RBP expression is distinct between B cells and T cells. Differentiation into effector and memory cells alters the RBP expression, resulting into preferential expression of different classes of RBPs. For instance, whereas naïve T cells express high levels of translation-regulating RBPs, effector T cells preferentially express RBPs that modulate mRNA stability. Lastly, we found that cytotoxic CD8+ and CD4+ T cells express a common RBP repertoire. Combined, our study reveals a cell type-specific and differentiation-dependent RBP expression landscape in human lymphocytes, which will help unravel the role of RBPs in lymphocyte function.

cytokines and chemokines, respectively. Cytotoxic T cells also acquire the capacity to kill target cells. The critical contribution of these lymphocyte subsets to anti-microbial and anti-tumor responses was evidenced by the discovery of genetic mutations in humans that result in immune dysfunction in response to infections (1) . Similarly, effective T cell responses are key for tumor immunosurveillance (2) .

Importantly, tight regulation of B cells and T cells effector function is key for effective clearance of infections. The aberrant production of antibodies by B cells, and the overproduction of effector molecules by T cells has been correlated with several autoimmune disorders, including systemic lupus erythematosus rheumatoid arthritis and multiple sclerosis (3) (4) (5) (6) . Likewise, patients suffering from severe disease upon COVID-19 infection developed auto-antibodies against type-I interferons (7) , and an excess cytokine production in COVID-19 patients can result in organ dysfunction (8) . Conversely, in chronic HIV infections or in tumors, T cells gradually lose their capacity to produce effector cytokines and to kill target cells (9, 10) .

These findings combined highlight the necessity to fine-tune the effector function of B cells and T cells.

To perform their effector function, B cells and T cells need to undergo an intricate process of differentiation. B cells differentiate into antibody-producing plasmablasts in germinal centers (GC), and upon pathogen clearance into long-lived memory B cells. Likewise, upon T cell priming, T cells differentiate into effector T cells, and upon pathogen clearance are maintained as memory T cells to ensure long-term production from recurring infections. In the past decennia, important insights have been obtained how B cells and T cell differentiate. In particular, the role of transcription factors and of metabolic regulators was extensively studied herein (11) (12) (13) (14) .

For appropriate lymphocyte differentiation, the regulators of differentiation processes must be produced at the right time and the right amount. In fact, gene dosage of transcription factors was shown to be key for B cell and T cell differentiation (15) (16) (17) (18) . This fine-tuning of gene expression is -at least in part -regulated by post-transcriptional events governed by RNAbinding proteins (RBPs) and non-coding RNAs (19, 20) . RBPs control a plethora of processes.

They orchestrate RNA splicing, RNA polyadenylation and the subsequent export from the nucleus to the cytoplasm (21, 22) . RBPs can also modify the RNA (23) . Furthermore, RBPs control mRNA localization, translation and stability. For instance, the RBPs ZFP36L1 and ZFP36L2 induce quiescence in developing B cells to allow for efficient B cell receptor rearrangement (24) . ZFP36L1 is also required for the maintenance of the marginal-zone B cell compartment (25) . For germinal center B cells that undergo cell cycle progression and affinity maturation, the expression of the RBP PTBP1 is key (26) . In thymocytes, ZFP36L1 and ZFP36L2 dampen the DNA-damage response, which promotes their differentiation into mature T cells (27) . In the periphery, Roquin suppresses T helper cell differentiation (28, 29) . Also m 6 A modifications are important for T helper cell differentiation, as evidenced in mice lacking the methyltransferase METTL3 in T cells (30) .

Not only T cell differentiation, but also T cell effector function is tightly regulated by RBPs.

Genetic ablation of the RBP Regnase-1 reprogrammed CD8 + T cells into long-lived effector CD8 + T cells, resulting in increased tumour control (31) . In a patient, a nonsense-mutation in REGNASE-1 resulted in hyperinflammation, including hypercytokinemia in T cells and monocytes (32) . Another example is ZFP36L2, which blocks the cytokine production in memory CD8 + T cells from pre-formed mRNA in the absence of activation signals, thereby preventing aberrant production of effector molecules (33) .

Even though these examples clearly highlight the importance of RBPs in regulating gene expression in lymphocytes, to date studies have addressed the contribution of individual RBPs.

documented, yet critical for our understanding of regulation of gene expression in lymphocytes.

In this study, we mapped the mRNA and protein expression of RBPs in primary human B cells and T cells. We observed clear differences of RBP expression levels between lymphocyte subsets. Furthermore, upon differentiation, the RBP expression profile significantly altered, which resulted in a shift of functional annotations of RBPs. Lastly, we identified an RBP signature that is specific for CD4 + T cells and CD8 + T cells with a high cytotoxic potential. In conclusion, RBP expression is lymphocyte-type specific and the RBP expression shows dynamic changes upon differentiation.

To investigate the overall mRNA and protein expression of RBPs in human lymphocytes, we first generated a comprehensive list of RBPs. We included RBPs that were identified by RNAinteractome capture on multiple cell lines including, HEK293, HeLa-S3, MCF7, MCF10A, U2OS and Jurkat cells (34) (35) (36) . This list was supplemented with computationally predicted RBPs based on the presence of a defined list of RNA-binding domains (RBDs) (36, 37) . This compiled list resulted in 3233 unique RBPs ( Figure 1A , Supplementary Table 1) .

To define the global RBP gene expression in human B and T lymphocytes, we compiled previously published RNA-sequencing (RNA-seq) data on human CD19 + B cell, CD4 + T cell and CD8 + T cell subsets that were isolated from the blood of 3-4 healthy human donors (38) .

On average, 12.5x10 6 reads per sample (range: 7.97x10 6 -19. To calculate the number of RBPs expressed at the protein level in B and T lymphocytes, we used previously published mass spectrometry (MS) data of B cell and T cell subsets of 4 donors (40) that were similarly prepared and selected as the ones in the RNA-seq dataset we used (38) .

In total, 9436 proteins were identified in all B cell and T cell subsets combined, of which 96.8% (9136 proteins) were also expressed at the RNA level (Supplementary Figure 1C) . Overall, 2617 RBPs (80.9% of our reference list) were detected at the protein level ( Figure 1B) , and 2596 RBPs (80.2%) were detected at both RNA and protein level ( Figure 1B ). This high overlap corroborated with the overall high expression levels of RBPs ( Figure 1C ; p-value: 6.2e-12 for RNA and 2.1e-12 for protein). The top 20 expressed RBPs at RNA level included several ribosomal proteins (RPL3, RPL4, RPS3, RPS27), translation-related proteins (EEF1A1, EEF1G, EIF1) and splicing-related proteins (DDX5 (41) , SRSF5 (42) , HNRNPA1 (43); Figure   1D ). At protein level, top 20 expressed RBPs included the RNA stability-related protein (VIM (44) ), the splicing-related protein HNRNPA2B1 (45) , the ribosomal protein RPS27A, and the moonlighting RBPs ENO1 and GAPDH ( Figure 1D , (46, 47) ).

Next, we determined which RNA-binding domains (RBDs) are present in the detected RBPs.

Using previously reported RBDs (Supplementary Table 1 , (36, 37) ) and the protein families annotation database (Pfam; (48)), we detected a broad range of RBDs. (Supplementary Table   1 ). The top 20 RBDs included classical RBDs, such as the RNA-recognition motif (RRM; 5.8%, present in e.g. CELF2, CNOT4, ELAVL2, HNRNPLL and PABPC1) and the DEAD helicase motif (DEAD; 2.1%, present in e.g. DDX1, DDX10, DHX16). Also a variety of zinc-finger protein domains was found, including the zinc-finger C2H2 (zf C2H2; 3.2%, present in e.g.

ZNF638, ZMAT3), zinc-finger metazoans (zf-met; 1.1%, present in e.g. ZFR2, TUT1), zincfinger CCCH (zf-CCCH; 1.0%, present in e.g. ZFP36L1, RBM27, ZC3H10), zinc-finger CCHC (zf-CCHC; 0.5%, present in e.g. ZCRB1, CPSF4) and the zinc-finger Ran binding protein (zf-RanBP; 0.5%, present in e.g. RBM5, RBM10, Figure 1E ). In addition, 52.8% of the RBPs contained non-canonical RNA-binding domains (1574 RBPs; Figure 1E RBPs regulate many processes, which includes RNA splicing, stability, subcellular localization of RNA, RNA modification, and translation (5, 49) . Using protein annotations from the human protein atlas database (50), we found that 1178 RBPs (41.7%) were annotated as regulators of at least one of these five RNA-related processes ( Figure 1F , left panel), of which 24% were annotated for multiple RNA-related processes ( Figure 1F , right panel). Combined, these data show that human lymphocytes express a wide variety of RBPs with a diverse set of RBDs.

To determine whether and how RBP expression differed between B cells and T cells, we analyzed CD19 + B cells, CD4 + T cells, and CD8 + T cells separately in the RNA-seq and MS datasets employed in Figure 1 . Overall, 2923 RBPs (97.0% of the total RBPs) and 2556 RBPs (97.6% of the total RBPs) were detected in all three subsets at the RNA and the protein level, respectively (Supplementary Figure 2A, B) . Only few RBPs were identified in one cell type alone (Supplementary Figure 2A) . In particular, B cells exclusively expressed members of the ribonuclease A super-family (RNASE1, RNASE2 and RNASE3) and the RBP DAZL. The RBPs RBM24 and PABPC3 were only detected in CD4 + T cells, and NCBPL2 and A1CF were specifically expressed in CD8 + T cells (Supplementary Table 2) . At the protein level, 36 RBPs were specifically detected in CD4 + T cells and CD8 + T cells (e.g. RC3H1, REXO1, HENMT1).

KHDRBS2, RPL37, DHX32 were for instance exclusively detected in CD19 + B cells and CD4 + T cells and CPEB2 and TRMT44in CD4 + T cells alone (Supplementary Table 2 Conversely, only 17.8% was annotated for RNA splicing in B cells, but reached 30.6% in T cells ( Fig 2F, right panel) . In conclusion, the overt differential RBP expression between human B cells and T cells shown here possibly reflects a distinct distribution between different classes of RBPs.

Several B cell subsets can be found in the peripheral blood including naïve B cells, memory B cells and plasmablasts ( Figure 3A ). Whereas plasmablasts produce vast quantities of antibodies and are short-lived, memory B cells are long-lived and for the most part quiescent (51) . We found that the phenotypical differences between these three B cell subsets is echoed in their RBP expression profile. We identified 1308 DE RBPs at RNA level, and 96 DE RBPs at protein level between naïve B cells, memory B cells and plasmablasts (Supplementary Figure 3A Table 3) . 188 RBPs were highly expressed in plasmablasts (cluster 1), 541 RBPs were highly expressed in memory B cells (cluster 2) and cluster 3 with 579 RBPs were highly expressed in naïve and memory B cells, respectively (cluster 3).

Hierarchical clustering on protein levels revealed similar differential RBP expression patterns Figure 3G ). For transport-annotated RBPs from cluster 1 (plasmablast), the interaction networks included the RBP SLBP, which regulates mRNA export (52) , and the RBP TST, which regulates the transport of ribosomal RNA ( Figure 3H , (53)). In conclusion, the RBP expression differs between B cell subsets, and involves different types of post-transcriptional regulatory functions.

Naïve T cells (Tnaive) undergo differentiation into effector T cells, which are rarely found in the peripheral blood of healthy donors (54) . Rather, central memory (Tcm) and effector memory Table 4 ). This differential expression of RBPs was also apparent at the protein level ( Figure 4E , 115 DE RBPs, Supplementary Table 4 ). To gain more insights into the biological processes of the RBPs in the different clusters, we performed Gene Ontology (GO) analysis. Whereas metabolic processes were enriched in all three clusters, cluster 2 and 3 were enriched for GO-terms associated with translation (translation initiation, cytoplasmic translation) and with RNA transport (Supplementary Figure 4D ). Cluster 2 also showed a moderate enrichment for RBPs associated with regulation of RNA stability (RNA destabilization, 3'-UTR-mediated mRNA destabilization; Supplementary Figure 4D ).

When we specifically isolated RBPs annotated for RNA splicing, stability, subcellular localization of RNA, RNA modification, and translation, we found that 103 (39.2%) RBPs of the DE RBPs belong to these 5 RBP classes in cluster 1, 148 RBPs in cluster 2 (40.4%) and 84 RBPs in cluster 3 (57.9%) ( Figure 4F , left panels). Only a fraction of RBPs is associated with more than one of these functions (cluster 1: 17.5%, cluster 2: 26.4%, cluster 3: 25%; Figure 4F , middle panel). When CD4 + T cells differentiate, the relative distribution of functional RBP annotation alters. 83.3% of the RBPs associated with the 5 RBP classes were linked to translation in cluster 3 (Tcm), compared to 51.5% and 43.2% in cluster 1 (Tnaive) and cluster 2 (Tem), respectively ( Figure 4F, right panels) . Conversely, in cluster 2 (Tem), the percentage of RBPs annotated for RNA transport are with 41.2% primarily found in cluster 2 and much less so in cluster 2 and 3 with 15.5% and 13.1%, respectively ( Figure 4F, right panels) .

STRING-analysis on the translation-related RBPs of cluster 3 revealed an enrichment of 53 ribosomal proteins and of other translation-associated RBPs, such as PABPC1, YBX1 and FAU ( Figure 4G ). The RNA-transport-related RBPs of cluster 2 included the mRNA exportassociated RBPs DDX19B, SARNP, MAGOH and THOC2 ( Figure 4H ). Combined, our findings reveal that the RBP expression landscape changes throughout CD4 + T cell differentiation, which results in a relative enrichment of specific RBP classes in different CD4 + T cell subsets.

We then focused on the CD8 + T cell differentiation subsets. Our dataset also included effector CD8 + T cells (Teff), which was included in the analysis, in addition to Tnaive, Tcm and Tem Table 5 ).

In CD8 + T cell subsets, 67 RBPs in cluster 1 (38.1%), 84 RBPs in cluster 2 (35.9%), and 143 RBPs in cluster 3 (48.1%) were annotated as regulators of RNA splicing, stability, subcellular localization of RNA, RNA modification, or translation ( Figure 5F , left panels), with a minority of RBPs (20-28%) linked to multiple functions ( Figure 5F , middle panels). We found that cluster 3 was relatively enriched for translation-associated RBPs (71.3%), compared to cluster 1 and cluster 2 with 34.5% and 44.8%, respectively ( Figure 5F , right panels). Conversely, cluster 1 and 2 were enriched for RBPs associated with RNA transport (cluster 1: 43.3%, cluster 2: 46.4%), and this RBP class was 12.6% only minor in cluster 3 ( Figure 5F , right panels).

STRING-analysis on translation-associated RBPs from cluster 3 revealed the interaction network between 56 ribosomal proteins and 10 eukaryotic translation initiation factors ( Figure   5G ). The RNA-transport associated RBPs in cluster 2 and 3 included RBPs involved in RNA export (THOC5 (56), RBM8A (57), SARNP (58), Figure 5H ).

Gene Ontology (GO) analysis on the DE RBPs also showed in cluster 3 -in addition to catabolic processes -an enrichment of GO-terms associated with translation, i.e. cytoplasmic translation, translation initiation and positive regulation of translation (Supplementary Figure 5D) . Cluster 1 displayed a moderate enrichment for GO-terms related to RNA stability (3'-UTR-mediated mRNA destabilization, regulation of mRNA stability, Supplementary Figure 5D ). In conclusion, CD8 + T cells change their RBP expression landscape throughout differentiation, with specific RBP classes enriched in different CD8 + T cell subsets.

T cells can acquire cytotoxic function when they differentiate into effector cells. Importantly, whereas CD8 + T cells are generally classified as cytotoxic, not all CD8 + T cells display cytotoxic features (59) (60) (61) . Conversely, a subset of human CD4 + T cells also shows cytolytic features (62) (63) (64) . We therefore sought to identify RBPs that were associated with a high cytotoxic capacity in human CD8 + T cells and CD4 + T cells. As source of T cells, we used previously published single-cell RNA-seq (scRNA-seq) data on blood-derived human CD8 + and CD4 + T cells (65) (66) (67) . Figure   6D , E). In addition, 16 RBPs were significantly upregulated in CD8 + T cells with a low cytotoxic score, whereas 36 RBPs were preferentially expressed in CD8 + T cells with a high cytotoxic score ( Figure 6D , Supplementary Table 6; LFC>0.5; P-adjusted<0.01). Likewise, 87

RBPs and 41 RBPs were upregulated in CD4 + T cells with a low and with a high cytotoxic score, respectively ( Figure 6E, Supplementary Table 6 ). Intriguingly, the differential RBP expression between CD8 + and CD4 + T cells with a low or high cytotoxic score was strikingly similar ( Figure 6F ). 13 RBPs were upregulated in CD8 + and CD4 + T cells with a low cytotoxic score ( Figure 6F ), which included 8 ribosomal proteins, e.g.

RPL13A, RPL10 and RPL4 which are accessory to the translation regulation (68) , and the translation initiation factor EEF1G ( Figure 6G, H) . 25 RBPs that were upregulated in both CD8 + and CD4 + T cells with a high cytotoxic score ( Figure 6F ) included cytidine deaminases APOBEC3G and APOBEC3C, the poly(G) binding protein ANXA2 (69), the viral dsRNA binder OASL (70) and the translational repressor PATL2 ( Figure 6G , H, (71)). In summary, CD8 + and CD4 + T cells with a high cytotoxic potential express a specific set of RBPs.

In this report, we provide a comprehensive RBP expression map based on the transcriptome and proteome of human B cells and T cells. We found that the overall expression pattern of RBPs is remarkably well conserved. It overlaps for >90% with that of HeLa-S3 cells and K562 cells. Nonetheless, differential expression analysis of RBPs clearly distinguishes B cells from for RBPs annotated for RNA transport, a feature that may support their antibody producing function. Effector and effector memory type CD4 + and CD8 + T cells also showed a preference of RBPs annotated for RNA transport, albeit to a lesser extent. Conversely, central memory CD4 + T cells, and naïve and central memory CD8 + T cells preferentially express RBPs that are annotated for translation regulation. This finding is in line with recent studies that indicated a tight gene-specific regulation of translation in naïve T cells (72) (73) (74) (75) , and the concept of translational preparedness of naïve and memory T cells (72) . It is therefore tempting to speculate that the enrichment for RBPs involved in translation regulation we find here contributes to the translation control in naïve and memory T cells.

Also, cytotoxic T cells display a unique RBP expression profile. Compared to non-cytotoxic T cells, cytotoxic T cells express lower mRNA levels of several ribosomal proteins. Whether the differences at the mRNA level for ribosomal proteins is also reflected at the protein level is still unknown. In addition, whether some of these ribosomal proteins display any transcript specificity, as was shown for RPL10A and RPS25 (68), remains to be defined. In addition, we noticed an increased expression of the mRNA cytidine deaminases APOBEC3C and APOBEC3G. Previous studies reported that APOBEC expression increases upon T cell activation (76) , which was primarily associated with viral restriction (77) . It is also conceivable that increased APOBEC expression is involved in regulating the fate of endogenous mRNAs in cytotoxic T cells. Interestingly, the specific RBP profile linked to cytotoxicity is shared by CD4 + T cells and CD8 + T cells, a feature which may point to a similar differentiation program towards cytotoxicity.

RNA-binding proteins are critical mediators in shaping lymphocyte differentiation and effector function (24) (25) (26) (27) (28) (30) (31) (32) (33) . The RBP expression map we provide here could help to further dissect the role of RBPs in B cell and T cell differentiation and function. It is important to note that the RBP expression map we provide here primarily serves as a resource, and thus as a starting point for uncovering the RBP-mediated regulation in lymphocyte differentiation. RBP expression by itself cannot be interpreted as direct interaction of RBPs with RNA. In fact, RBP interactions with RNAs can be highly versatile and are subject to rapid changes upon extrinsic signals. For instance, the RBP ZFP36L2 is expressed to a similar extent in memory T cells and re-activated T cells, yet only blocks translation in resting memory T cells (33) . Similarly, a large fraction of ribosomal proteins does not interact with ribosomal RNA. The mode of action of these nonribosomal RNA binding RPs is to date enigmatic and requires further investigation. Lastly, in addition to classical RBPs, recent studies have revealed the presence of enigmatic RBPs, which are primarily annotated for other cellular functions. This is exemplified by metabolic enzymes from the TCA cycle (78, 79) . Their relative contribution to RNA regulation during lymphocyte differentiation and effector function is yet to be experimentally confirmed. Nonetheless, the role of RBPs in genetic diseases is becoming appreciated (80) , and defining the RBP expression presented in the study presented here may contribute to deciphering dysregulated RBP expression and function also in immune-related diseases. 

ScRNA-seq datasets were analysed using Seurat (version 4.0.1;(86)). Count matrices of (65,67,82) were filtered for "PTC", corresponding to peripheral blood-derived CD8 + T cells (CD3 + CD8 + ). To identify conventional blood-derived CD4 + T cells, count matrices of references (65, 67, 82) were filtered for "PTH" (CD3 + CD4 + CD25 -) and "PTY" (CD3 + CD4 + CD25 int ). To correct for dataset specific effects from the three individual scRNAseq datasets, we employed a published scRNA-seq data integration method (87) . The interindividual donor batch-effect was corrected using the vars.to.regress argument in SCTransform (Seurat v4). Unsupervised clustering was performed on Uniform Manifold Approximation and Project (UMAP) dimensional reduction using the top 30 principal components (PCs). Cells expressing high levels of naive T cell associated genes like CCR7, LEF1 and SELL (88, 89) were excluded from downstream analysis. Differential gene expression analysis was performed using the Model-based Analysis of Single-cell Transcriptomics (MAST) test (90) . Genes were considered differentially expressed based on a p-adjusted < 0.05 and an absolute log2 fold change > 0.5.

The cytotoxic score of CD4 + T cells and CD8 + T cells was obtained from the scRNA-seq data by selecting for the top 7 most correlated (Pearson's correlation) genes with FGFBP2 expression (9) . (Supplementary Figure 6A Table 1 ).

Proteins containing RNA-binding domains were obtained from the PFAM database. When RBPs contained more than one RBD, each RBD was counted and included in the analysis.

Human Protein Atlas annotations (HPA, https://www.proteinatlas.org on 28-03-2021; (50)) were used to classify proteins associated with RNA modification (keywords: "RNA AND Modification"), RNA splicing (keywords: "Spliceosome"), RNA stability (keywords: "RNA AND Stability"), RNA transport (keywords: "RNA AND Transport"), and Translation (keywords: "Translation"). Protein-protein association networks were generated using the STRING database (https://string-db.org/, (92) 

Plots and graphs were generated using ggplot2 (version 3.3; (94) 

Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories

The immunobiology of cancer immunosurveillance and immunoediting

Effector functions of CD4+ T cells at the site of local autoimmune inflammation-lessons from rheumatoid arthritis

Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis

Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS

Development of auto-antibodies before the clinical onset of systemic lupus erythematosus

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

T-cell exhaustion in HIV infection

Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses

BACH2 regulates CD8 + T cell differentiation by controlling access of AP-1 factors to enhancers

Metabolic regulation of T lymphocytes

Metabolic Regulation of the Immune Humoral Response

Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation

A Role for the Transcriptional Repressor Blimp-1 in CD8+ T Cell Exhaustion during Chronic Viral Infection

Protein Amounts of the MYC Transcription Factor Determine Germinal Center B Cell Division Capacity

Antibody regulation of B cell development

MicroRNA regulation of CD8+ T cell responses

Dynamic post-transcriptional events govern T cell homeostasis and effector function

Understanding splicing regulation through RNA splicing maps

How cells get the message: Dynamic assembly and function of mRNA-protein complexes

Chemical Modifications to RNA: A New Layer of Gene Expression Regulation

RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence

Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1

The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers article

The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic β-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression

Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells

Regnase-1 and Roquin Nonredundantly Regulate Th1 Differentiation Causing Cardiac Inflammation and Fibrosis

M 6 A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways

Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy

A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation

Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells

Comprehensive Identification of RNA-Binding Domains in Human Cells

Discovery of RNA-binding proteins and characterization of their dynamic responses by enhanced RNA interactome capture

EuRBPDB: a comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs)

A census of human RNA-binding proteins

RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types

Accurate annotation of human protein-coding small open reading frames

Social network architecture of human immune cells unveiled by quantitative proteomics

DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia

Novel delayedearly and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing

Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2

A Novel Role of Vimentin Filaments: Binding and Stabilization of Collagen mRNAs

HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events

Metabolic Enzymes Enjoying New Partnerships as RNA-Binding Proteins

Posttranscriptional control of T cell effector function by aerobic glycolysis

Pfam: The protein families database

Uncovering the role of RNA-binding proteins in gene expression in the immune system

Tissue-based map of the human proteome

The generation of antibodysecreting plasma cells

The stem-loop binding protein forms a highly stable and specific complex with the 3′ stem-loop of histone mRNAs

Mitochondrial enzyme rhodanese is essential for 5 S ribosomal RNA import into human mitochondria

Reference values for peripheral blood lymphocyte subsets of healthy children in China

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

THOC5, a member of the mRNA export complex: A novel link between mRNA export machinery and signal transduction pathways in cell proliferation and differentiation

The exon junction complex component Y14 modulates the activity of the methylosome in biogenesis of spliceosomal small nuclear ribonucleoproteins

ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex

CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential

The Roles of CD8+ T Cell Subsets in Antitumor Immunity

SLAMF7 and IL-6R define distinct cytotoxic versus helper memory CD8+ T cells

CD29 enriches for cytotoxic human CD4 T cells

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

Tumor-specific cytolytic CD4 T cells mediate protective immunity against human cancer

Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

Deep single-cell RNA sequencing data of individual T cells from treatment-naïve colorectal cancer patients

Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing

Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide

Annexin A2 Is a Novel RNAbinding Protein

5′-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro

Distinct functions of maternal and somatic Pat1 protein paralogs

Dynamics in protein translation sustaining T cell preparedness

Quantitative analysis of T cell proteomes and environmental sensors during T cell differentiation

Active Tonic mTORC1 Signals Shape Baseline Translation in Naive T Cells

Translation is actively regulated during the differentiation of CD8 + effector T cells

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: Implications for HIV-1 restriction

Suppression of HIV-1 Infection by APOBEC3 Proteins in Primary Human CD4 + T Cells Is Associated with Inhibition of Processive Reverse Transcription as Well as Excessive Cytidine Deamination

The RNA-binding proteomes from yeast to man harbour conserved enigmRBPs

RNA regulates Glycolysis and Embryonic Stem Cell Differentiation via Enolase

RNA-binding proteins in human genetic disease

The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

Salmon provides fast and biasaware quantification of transcript expression

Differential analyses for RNA-seq: Transcript-level estimates improve gene-level inferences

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Spatial reconstruction of singlecell gene expression data

Comprehensive Integration of Single-Cell Data

Human Naive CD8 T Cells Down-Regulate Expression of the WNT Pathway Transcription Factors Lymphoid Enhancer Binding Factor 1 and Transcription Factor

following Antigen Encounter In Vitro and In Vivo

Transcriptome Signatures Reveal Rapid Induction of Immune-Responsive Genes in Human Memory CD8+ T Cells

MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

Proteomewide identification of ubiquitin interactions using UbIA-MS

STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

PANTHER version 14: More genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools

Elegant Graphics for Data Analysis

pheatmap: Pretty heatmaps

The authors would like to thank Drs. B. Popovic and I. Foskolou for critical reading of the manuscript.